Sažetak sa skupa

https://doi.org/10.15836/ccar2019.252

A patient with permanent atrial fibrillation and very high bleeding risk – when is the optimal time to refer for left atrial appendage occluder device implantation?

Sandra Prša ; Bjelovar General Hospital, Bjelovar, Croatia
Ivana Petrović Juren ; Bjelovar General Hospital, Bjelovar, Croatia
Ante Anić ; University Hospital Centre Split, Split, Croatia
Ivana Smoljan ; University Hospital Centre Rijeka, Rijeka, Croatia
Darija Baković Kramarić ; University Hospital Centre Split, Split, Croatia
Kristina Milevoj Križić ; Bjelovar General Hospital, Bjelovar, Croatia
Andreja Čleković- Kovačić ; Bjelovar General Hospital, Bjelovar, Croatia
Vlasta Soukup Podravec ; Bjelovar General Hospital, Bjelovar, Croatia
Iva Ladić ; Bjelovar General Hospital, Bjelovar, Croatia
Gabriela Bašković ; Bjelovar General Hospital, Bjelovar, Croatia

Sažetak

Introduction: Most patients with atrial fibrillation (AF) should receive anticoagulant therapy to reduce
the risk of systemic embolization. However, there are varying degrees of bleeding risk associated with
anticoagulation thus reducing the number of candidates for this therapy. The left atrial appendage
(LAA) is the usual source of clot embolisms. Percutaneous approaches, often referred to as LAA exclusion
procedures, mechanically prevent embolization of LAA thrombi.1,2 We consider the placement of
percutaneous LAA Occlusion Device (Amplatzer Amulet device) a good choice for patients with high
bleeding risk.

Ključne riječi

left atrial appendage; thrombus; bleeding risk; Amplatzer Amulet occluder device.

Hrčak ID:

226719

URI

https://hrcak.srce.hr/226719

Datum izdavanja:

15.10.2019.

Posjeta: 960 *